JAVELIN renal 101: A randomized, phase III study of avelumab plus axitinib vs sunitinib as first-line treatment of advanced renal cell carcinoma (aRCC)

被引:0
作者
Motzer, R. J. [1 ]
Penkov, K. [2 ]
Haanen, J. B. A. G. [3 ]
Rini, B. I. [4 ]
Albiges, L. [5 ]
Campbell, M. T. [6 ]
Kollmannsberger, C. K. [7 ]
Negrier, S. [8 ]
Uemura, M. [9 ]
Lee, J. L. [10 ]
Gurney, H. [11 ]
Berger, R. [12 ]
Schmidinger, M. [13 ,14 ]
Larkin, J. [15 ]
Atkins, M. B. [16 ]
Wang, J. [17 ]
Robbins, P. B. [18 ]
Chudnovsky, A. [19 ]
Di Pietro, A. [20 ]
Choueiri, T. K. [21 ,22 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Med, 1275 York Ave, New York, NY 10021 USA
[2] Private Med Inst Euromedserv, Med Oncol, St Petersburg, Russia
[3] Netherlands Canc Inst, Div Med Oncol, Amsterdam, Netherlands
[4] Cleveland Clin, Med Oncol, Cleveland, OH 44106 USA
[5] Inst Gustave Roussy, Dept Canc Med, Villejuif, France
[6] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA
[7] British Columbia Canc Agcy, Med Oncol, Vancouver, BC, Canada
[8] Ctr Leon Berard, Oncol Med, Lyon, France
[9] Osaka Univ Hosp, Med Oncol, Osaka, Japan
[10] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea
[11] Macquarie Univ, Med & Hlth Sci, Macquarie Pk, Australia
[12] Chaim Sheba Med Ctr, Inst Onocol & Radiotherapy, Ramat Gan, Israel
[13] Med Univ Vienna, Dept Med 1, Div Clin Oncol, Vienna, Austria
[14] Med Univ Vienna, Ctr Comprehens Canc, Vienna, Austria
[15] Royal Marsden NHS Fdn Trust, Dept Med Oncol, London, England
[16] Georgetown Lombardi Comprehens Canc Ctr, Oncol & Med, Washington, DC USA
[17] Pfizer, Oncol, Cambridge, MA USA
[18] Pfizer, Translat Oncol, San Diego, CA USA
[19] Pfizer, Immunooncol, Cambridge, MA USA
[20] Pfizer, Immunooncol, Milan, Italy
[21] Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Med Oncol, Boston, MA 02115 USA
[22] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
LBA6_PR
引用
收藏
页码:724 / 724
页数:1
相关论文
empty
未找到相关数据